Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

Alan Kennedy(Institute of Infection and Immunity), David M. Sansom(Institute of Infection and Immunity)
Nature Immunology
August 23, 2022
10.1038/s41590-022-01289-w
Cited by 208

Related Papers

Whole-genome sequencing of a sporadic primary immunodeficiency cohort
|Nature|2020|242
Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells
|European Journal of Immunology|2002|138
Regulation of CTLA‐4 recycling by LRBA and Rab11
|Immunology|2021|45
The CTLA‐4 immune checkpoint protein regulates PD‐L1:PD‐1 interaction via transendocytosis of its ligand CD80
|The EMBO Journal|2023|32